Roger Nosal

484 total citations
15 papers, 312 citations indexed

About

Roger Nosal is a scholar working on Organic Chemistry, Molecular Biology and Biochemistry. According to data from OpenAlex, Roger Nosal has authored 15 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Organic Chemistry, 4 papers in Molecular Biology and 4 papers in Biochemistry. Recurrent topics in Roger Nosal's work include Eicosanoids and Hypertension Pharmacology (4 papers), Oxidative Organic Chemistry Reactions (3 papers) and Nitric Oxide and Endothelin Effects (2 papers). Roger Nosal is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (4 papers), Oxidative Organic Chemistry Reactions (3 papers) and Nitric Oxide and Endothelin Effects (2 papers). Roger Nosal collaborates with scholars based in United States, United Kingdom and Poland. Roger Nosal's co-authors include Daniel L. Flynn, Daniel P. Becker, Thomas García, Gary W. Gullikson, Chafiq Moummi, Clara I. Villamil, Timothy Watson, David J. am Ende, Jason Mustakis and Frank Montgomery and has published in prestigious journals such as Journal of Medicinal Chemistry, Tetrahedron and Tetrahedron Letters.

In The Last Decade

Roger Nosal

15 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger Nosal United States 10 114 83 33 33 31 15 312
Julian A. Hudson United Kingdom 10 113 1.0× 86 1.0× 10 0.3× 27 0.8× 12 0.4× 16 259
Kristy Tran United States 13 303 2.7× 100 1.2× 17 0.5× 19 0.6× 57 1.8× 14 475
János Éles Hungary 11 150 1.3× 92 1.1× 7 0.2× 9 0.3× 32 1.0× 34 342
János Kóti Hungary 12 198 1.7× 85 1.0× 15 0.5× 16 0.5× 12 0.4× 27 296
Hugh Verrier United Kingdom 9 144 1.3× 112 1.3× 8 0.2× 25 0.8× 29 0.9× 15 295
Lucius T. Rossano United States 11 253 2.2× 137 1.7× 3 0.1× 12 0.4× 36 1.2× 13 382
Alcide Perboni Italy 13 365 3.2× 82 1.0× 10 0.3× 20 0.6× 16 0.5× 31 447
Den-ichi Momose Japan 10 139 1.2× 75 0.9× 16 0.5× 70 2.1× 35 1.1× 15 381
Neil S. Hodnett United Kingdom 11 153 1.3× 64 0.8× 3 0.1× 35 1.1× 47 1.5× 19 294
Karamjit S. Jandu United Kingdom 8 133 1.2× 149 1.8× 33 1.0× 7 0.2× 15 0.5× 9 370

Countries citing papers authored by Roger Nosal

Since Specialization
Citations

This map shows the geographic impact of Roger Nosal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Nosal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Nosal more than expected).

Fields of papers citing papers by Roger Nosal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Nosal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Nosal. The network helps show where Roger Nosal may publish in the future.

Co-authorship network of co-authors of Roger Nosal

This figure shows the co-authorship network connecting the top 25 collaborators of Roger Nosal. A scholar is included among the top collaborators of Roger Nosal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger Nosal. Roger Nosal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Watson, Timothy, et al.. (2018). Misunderstanding Design Space: a Robust Drug Product Control Strategy Is the Key to Quality Assurance. Journal of Pharmaceutical Innovation. 13(3). 283–285. 6 indexed citations
2.
Watson, Timothy, et al.. (2016). The Selection and Control of Starting Materials Should be Governed by Science and Risk-Based Approaches. The AAPS Journal. 19(1). 1–3. 7 indexed citations
3.
Watson, Timothy, Stephen T. Colgan, Michael P. Lynch, et al.. (2013). A Design Space Verification Protocol for a Small Molecule Drug Substance. Journal of Pharmaceutical Innovation. 8(2). 67–71. 1 indexed citations
4.
Colgan, Stephen T., et al.. (2012). The Application of Science- and Risk-Based Concepts to Drug Substance Stability Strategies. Journal of Pharmaceutical Innovation. 7(3-4). 205–213. 12 indexed citations
5.
García, Thomas, et al.. (2008). PQLI Key Topics - Criticality, Design Space, and Control Strategy. Journal of Pharmaceutical Innovation. 3(2). 60–68. 60 indexed citations
6.
Nosal, Roger, et al.. (2008). PQLI Definition of Criticality. Journal of Pharmaceutical Innovation. 3(2). 69–78. 25 indexed citations
7.
Ende, David J. am, et al.. (2007). API Quality by Design Example from the Torcetrapib Manufacturing Process. Journal of Pharmaceutical Innovation. 2(3-4). 71–86. 36 indexed citations
8.
Becker, Daniel P., Daniel L. Flynn, Roger Nosal, et al.. (2006). Pyrrolizidine Esters and Amides as 5-HT4 Receptor Agonists and Antagonists. Journal of Medicinal Chemistry. 49(3). 1125–1139. 38 indexed citations
9.
Becker, Daniel P., et al.. (1997). Synthetic strategies for the construction of enantiomeric azanoradamantanes. Tetrahedron. 53(1). 1–20. 12 indexed citations
10.
Becker, Daniel P., Roger Nosal, Clara I. Villamil, et al.. (1997). Serotonin 5-HT4 agonist activity of a series of meso-azanoradamantane benzamides. Bioorganic & Medicinal Chemistry Letters. 7(17). 2149–2154. 5 indexed citations
11.
Nosal, Roger, et al.. (1994). Zinc mediated addition of active halides to a glycine cation equivalent: Synthesis of N-Boc-L-propargylglycine. Tetrahedron Letters. 35(22). 3669–3672. 11 indexed citations
12.
Flynn, Daniel L., Daniel P. Becker, Roger Nosal, et al.. (1992). SC-53116: the first selective agonist at the newly identified serotonin 5-HT4 receptor subtype. Journal of Medicinal Chemistry. 35(8). 1486–1489. 72 indexed citations
13.
14.
Flynn, Daniel L., Daniel P. Becker, Dale Spangler, et al.. (1992). New aza(nor)adamantanes are agonists at the newly identified serotonin 5-HT4 receptor and antagonists at the 5-HT3 receptor. Bioorganic & Medicinal Chemistry Letters. 2(12). 1613–1618. 11 indexed citations
15.
Flynn, Daniel L., et al.. (1992). Use of atom-transfer radical cyclizations as an efficient entry into a new “serotonergic” azanoradamantane. Tetrahedron Letters. 33(48). 7283–7286. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julian A. Hudson Breakdown of academic impact, for papers by Kristy Tran Breakdown of academic impact, for papers by János Éles Breakdown of academic impact, for papers by János Kóti Breakdown of academic impact, for papers by Hugh Verrier Breakdown of academic impact, for papers by Lucius T. Rossano Breakdown of academic impact, for papers by Alcide Perboni Breakdown of academic impact, for papers by Den-ichi Momose Breakdown of academic impact, for papers by Neil S. Hodnett Breakdown of academic impact, for papers by Karamjit S. Jandu
Rankless by CCL
2026